PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Protein clamps tight to telomeres to help prevent aging...and support cancer

Wistar scientists first to uncover structure and mechanism of Cdc13

2010-09-15
(Press-News.org) The number of times our cells can divide is dictated by telomeres, stretches of DNA at the tips of our chromosomes. Understanding how telomeres keep our chromosomes – and by extension, our genomes – intact is an area of intense scientific focus in the fields of both aging and cancer. Now, scientists at The Wistar Institute have published the first detailed report on the structure and function of a crucial domain in the protein known as Cdc13, which sustains telomeres by clamping to DNA and recruiting replicating enzymes to the area.

While the nature of this portion of Cdc13 had previously eluded scientists, the Wistar researchers found that two copies of the protein bind together to form what is called a "dimer," and how that dimer physically interacts with DNA, regulating how enzymes called telomerases access and lengthen the telomeres. The study was performed using the yeast gene, however, this essential life process has changed little through evolution, and evidence suggests that the human equivalent of this protein may make a good target for future anticancer drugs. They present their findings in the journal Molecular and Cellular Biology, available online now, ahead of print.

"Cdc13 has a crucial support role in maintaining and lengthening telomeres, which are reduced in length through every round of DNA replication," said Emmanuel Skordalakes, Ph.D., assistant professor in Wistar's Gene Expression and Regulation Program and senior author of the study. "We know that disabling this protein in humans will most likely lead to senescence, which is of particular interest in cancer, because telomere lengthening is one of the ways cancer cells obtain their immortality."

In the present study, Skordalakes and his colleagues detail how Cdc13 serves a dual function in telomere replication. First, it keeps the cells' natural DNA repair mechanisms from mistaking the telomere for a broken stretch of DNA, which could cause genetic mayhem if such repair proteins fuse the ends of two chromosomes together, for example. Secondly, Cdc13 recruits telomerase and related proteins to place in order to lengthen the telomeres.

When the researchers introduced mutations into Cdc13 that prevented the protein from forming a dimer, it caused the telomeres to shorten, which would hasten the demise of the yeast cells. When they created mutations that prevented Cdc13 dimers from binding to DNA, it had the effect of excessively lengthening telomeres, an act the researchers attribute to the notion that Cdc13 helps regulate the ability of DNA-replication enzymes to access telomeres.

"The complex role of Cdc13 underscores the unique nature of telomeres and the fine balance between normal cell division and cancer," said Skordalakes.

Telomeres are important to cell division because they serve as sort of a timing mechanism that can, in effect, limit the number of times a normal cell can divide. As each cell divides, it must first replicate – or copy – the DNA of its chromosomes in exacting detail.

However, the proteins in cells that make this replication possible physically cannot copy the last few base units of DNA at the tips of the chromosomes, which effectively shortens the telomere each time a chromosome is copied. Without telomeres to serve as a buffer, a chromosome could conceivably lose a functioning gene as it is copied. This natural "lifespan" of cells was first identified in the 1960s as the Hayflick Limit, named after its discoverer, Leonard Hayflick, Ph.D., then a Wistar scientist.

In 2008, the Skordalakes laboratory was the first to determine the 3-D structure of the catalytic subunit of the enzyme telomerase, which functions to tack on the short stretches of DNA at the telomeres that the cell's main DNA-replicating enzymes miss. The act of preserving telomeres through telomerase is a hallmark of only certain cells, particularly those in developing embryos. In adults, telomerase is active in stem cells, certain immune system cells and, most notably, cancer cells.

According to Skordalakes, the discovery of the dimeric nature of Cdc13 sheds light into the core function of this protein, the recruitment of telomerase (which is also a dimer) to the telomeres. Within the Cdc13 dimer are multiple sites that can bind to DNA with varying degrees of affinity. This allows Cdc13 to straddle the DNA so that one section grips tightly to DNA, while another section – with a more relaxed grip – can bind nearer the tail end of the DNA strand and where telomerase binds. This feature of Cdc13 also assists in recruiting telomerase, summoning the enzyme into place above the telomere.

"You can think of Cdc13 as if it were you hanging on to the edge of a cliff, with one grip stronger than the other," Skordalakes said. "You're going to keep that strong hand on the cliff's edge while your weaker hand reaches into your pocket for your phone."

When Cdc13 interacts with telomerase, Skordalakes says, its weaker hand lets go of DNA, allowing the telomerase to access the telomere while the "strong hand" keeps the telomerase-Cdc13 complex firmly attached to the chromosome end. "It effectively serves as both a protective placeholder and a means of guiding telomerase activity," Skordalakes said.

The Skordalakes laboratory continues to explore the complex biology of telomeres, as well as the numerous other proteins necessary for telomere lengthening to occur. Meanwhile, they are investigating the potential of small molecule inhibitors to serve as viable therapeutics against cancer by blocking telomerase and their related proteins.

INFORMATION: Co-authors from The Wistar Institute include David W. Speicher, Ph.D., a Wistar professor, and laboratory staff Meghan Mitchell (a former research assistant under Skordalakes), Mark Mason (a graduate student under Skordalakes), and Sandy Harper (a technician under Speicher). They were joined by Jasmine S. Smith and F. Brad Johnson, M.D., Ph.D., from the University of Pennsylvania School of Medicine's Department of Pathology and Laboratory Medicine.

The research was supported by grants from the Pennsylvania Department of Health, The Ellison Medical Foundation, The Emerald Foundation, Inc., and the National Institute on Aging of the National Institutes of Health.

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today's Discoveries – Tomorrow's Cures. On the Web at www.wistar.org.


ELSE PRESS RELEASES FROM THIS DATE:

NASA satellite measures monstrous Hurricane Igor as a '10 hour drive'

NASA satellite measures monstrous Hurricane Igor as a 10 hour drive
2010-09-15
Hurricane Igor is a monster hurricane in terms of strength and size. To get a perspective on its size, it is the same distance from one end of the storm to the other as it is from Boston, Mass. to Richmond, Va., some 550 miles. That's a 10-hour drive from one end to the other, and NASA satellites captured that entire distance in one image. Because Hurricane Igor is a large storm and even if Igor doesn't make a direct landfall in Bermuda, the extent of the winds (the wind field) is so large that the National Hurricane Center noted that Bermuda can be buffeted by winds ...

Discovery of the secrets that enable plants near Chernobyl to shrug off radiation

2010-09-15
Scientists are reporting discovery of the biological secrets that enable plants growing near the Chernobyl Nuclear Power Plant to adapt and flourish in highly radioactive soil — legacy of the 1986 nuclear disaster in the Ukraine. Their study, which helps solve a long-standing mystery, appears in ACS' Environmental Science & Technology, a semi-monthly journal. Martin Hajduch and colleagues note that plants have an unexpected ability to adapt to an environment contaminated with radiation following the April 26, 1986 accident at Chernobyl. Their previous research, for example, ...

Quick-intensifying Tropical Storm Karl landfalling in Mexico

Quick-intensifying Tropical Storm Karl landfalling in Mexico
2010-09-15
NASA's Aqua satellite captured the birth of Tropical Storm Karl on Sept. 14 as it passed overhead at 3:05 p.m. EDT in the Caribbean. This morning, Karl made landfall in the east coast of the Yucatan Peninsula, Mexico. By 5 p.m. EDT on Sept. 14, System 92L intensified quickly in the western Caribbean and became the thirteenth tropical depression that quickly fired up into Tropical Storm Karl. NASA's Aqua satellite was flying overhead at 3:05 p.m. EDT and the Moderate Resolution Imaging Spectroradiometer (MODIS) instrument captured a visible image of Karl as he was rapidly ...

Carbon nanotubes twice as strong as once thought

2010-09-15
Carbon nanotubes — those tiny particles poised to revolutionize electronics, medicine, and other areas — are much bigger in the strength department than anyone ever thought, scientists are reporting. New studies on the strength of these submicroscopic cylinders of carbon indicate that on an ounce-for-ounce basis they are at least 117 times stronger than steel and 30 times stronger than Kevlar, the material used in bulletproof vests and other products. The findings, which could expand commercial and industrial applications of nanotube materials, appear in the monthly journal ...

Aerobic exercise relieves insomnia

2010-09-15
CHICAGO --- The millions of middle-aged and older adults who suffer from insomnia have a new drug-free prescription for a more restful night's sleep. Regular aerobic exercise improves the quality of sleep, mood and vitality, according to a small but significant new study from Northwestern Medicine. The study is the first to examine the effect of aerobic exercise on middle-aged and older adults with a diagnosis of insomnia. About 50 percent of people in these age groups complain of chronic insomnia symptoms. The aerobic exercise trial resulted in the most dramatic ...

New evidence on how cranberry juice fights bacteria that cause urinary tract infections

2010-09-15
Scientists reported new evidence on the effectiveness of that old folk remedy — cranberry juice — for urinary tract infections at the ACS' 240th National Meeting. "A number of controlled clinical trials — these are carefully designed and conducted scientific studies done in humans — have concluded that cranberry juice really is effective for preventing urinary tract infections," said Terri Anne Camesano, Ph.D., who led the study. "That has important implications, considering the size of the problem and the health care costs involved." Estimates suggest that urinary tract ...

Progress on vaccine for 'Ich,' bane of fish farms and home aquarium hobbyists

2010-09-15
Tests of a potential vaccine against "Ich" — the dreaded "white-spot" disease that plagues fish in commercial fish farms, public aquariums, pet fish retail outlets, and home aquariums — are raising hopes for finally controlling the disease, scientists reported at the 240th National Meeting of the American Chemical Society. "Outbreaks of the parasitic disease caused by Ichthyophthirius (Ich) can result in losses of 50-100 percent of fish," Dehai Xu, Ph.D., said. "The disease is very common, and almost every home fish hobbyist has encountered it. Once the parasite infects ...

Secret funding fosters hope for new drugs for autism

2010-09-15
Funding from an anonymous wealthy family has been the secret to progress, at long last, in developing drugs that show promise for helping millions of people worldwide with Fragile X syndrome, the most common genetic cause of autism. That's the topic of a fascinating article in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. C&EN Senior Editor Lisa Jarvis notes that until recent interest from big pharmaceutical companies, a small drug company in Cambridge, Mass. named Seaside Therapeutics was virtually the only company trying to develop ...

Facial recognition technology aimed at spotting terrorists

2010-09-15
Rapid improvements in facial-recognition software mean airport security workers might one day know with near certainty whether they're looking at a stressed-out tourist or staring a terrorist in the eye. A research team led by Dr. Alice O'Toole, a professor in The University of Texas at Dallas' School of Behavioral and Brain Sciences, is evaluating how well these rapidly evolving recognition programs work. The researchers are comparing the rates of success for the software to the rates for non-technological, but presumably "expert" human evaluation. "The government ...

New investigational compound targets pancreatic cancer cells

2010-09-15
SCOTTSDALE, Ariz. (Sept. 14, 2010) – A new investigational drug designed to penetrate and attack pancreatic cancer cells has been administered to a patient for the first time ever at the Virginia G. Piper Cancer Center at Scottsdale Healthcare. ASG-5ME is a potent, targeted compound designed to selectively kill cancer cells, says Daniel Von Hoff, MD, a principal investigator in the Phase I clinical trial. Pancreatic cancer is a fast-growing and difficult to treat form of cancer, and is the fourth leading cause of cancer death in the United States. "ASG-5ME is intended ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] Protein clamps tight to telomeres to help prevent aging...and support cancer
Wistar scientists first to uncover structure and mechanism of Cdc13